Rady Childrens Hospital - San Diego
- Type
- Teaching hospital
- Where
- SAN DIEGO, CA
- Medicare CCN
- 053303
- Received
- $147,930 in 40 records, 2024 ($131,223 general, $16,706 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
- Nonprofit: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2024 | General payment | 28 | $131,223 |
| 2024 | Research payment | 12 | $16,706 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| OrthoPediatrics Corp. | 3 | $57,651 | 2024 |
| Siemens Medical Solutions USA, Inc. | 3 | $17,250 | 2024 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $13,500 | 2024 |
| National Marrow Donor Program | 7 | $11,380 | 2024 |
| MED-EL Corporation | 2 | $10,290 | 2024 |
| Medtronic, Inc. | 1 | $5,251 | 2024 |
| Chiesi USA, Inc. | 1 | $5,000 | 2024 |
| Celgene Corporation | 1 | $5,000 | 2024 |
| Mirati Therapeutics, Inc. | 1 | $5,000 | 2024 |
| Becton, Dickinson and Company | 1 | $3,701 | 2024 |
| Novartis Pharmaceuticals Corporation | 1 | $3,275 | 2024 |
| E.R. Squibb & Sons, L.L.C. | 1 | $2,093 | 2024 |
| Sarepta Therapeutics, Inc. | 5 | $1,999 | 2024 |
| Stryker Corporation | 3 | $1,396 | 2024 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $1,061 | 2024 |
| Baxter Healthcare | 1 | $1,000 | 2024 |
| Mylan Specialty L.P. | 1 | $1,000 | 2024 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $1,000 | 2024 |
| Insulet Corporation | 1 | $500 | 2024 |
| Edwards Lifesciences Corporation | 1 | $305 | 2024 |
| Abbott Laboratories | 1 | $250 | 2024 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Grant | 7 | $78,851 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 7 | $25,605 |
| Research payment | 12 | $16,706 |
| Long term medical supply or device loan | 4 | $14,223 |
| Space rental or facility fees (teaching hospital only) | 7 | $12,250 |
| Debt forgiveness | 2 | $269 |
| Charitable Contribution | 1 | $25 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | Becton, Dickinson and Company | $3,701 | Long term medical supply or device loan | In-kind items and services | HemoSphere Device, Hemodynamic Monitoring | 2024 | |
| 2024-12-31 | Stryker Corporation | $1,126 | Long term medical supply or device loan | In-kind items and services | RemB Device, INSTRUMENTS | 2024 | |
| 2024-12-31 | Stryker Corporation | $212 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-12-31 | Stryker Corporation | $57 | Debt forgiveness | Cash or cash equivalent | 2024 | ||
| 2024-11-18 | Siemens Medical Solutions USA, Inc. | $5,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-11-18 | Abbott Laboratories | $250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-11-05 | Siemens Medical Solutions USA, Inc. | $10,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-10-25 | National Marrow Donor Program | $2,755 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-10-10 | Baxter Healthcare | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Hillrom - Vest System Model 105 Home Care Device, Airway Clearance Device | 2024 | |
| 2024-10-02 | Chiesi USA, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELFABRIO Drug, ERT FOR FABRY DISEASE | 2024 | |
| 2024-09-20 | Celgene Corporation | $5,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-09-19 | E.R. Squibb & Sons, L.L.C. | $2,093 | Research payment | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | Mavacamten Pediatrics Global Study | 2024 |
| 2024-09-16 | OrthoPediatrics Corp. | $15,615 | Grant (4 payments) | Cash or cash equivalent | 2024 | ||
| 2024-09-03 | Mylan Specialty L.P. | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TOBI PODHALER Drug, Aminoglycosides | 2024 | |
| 2024-08-07 | MED-EL Corporation | $9,090 | Long term medical supply or device loan | In-kind items and services | Mi1250 SYNCHRONY 2 FLEXsoft Device, Cochlear Implant | 2024 | |
| 2024-07-26 | National Marrow Donor Program | $1,725 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-07-26 | National Marrow Donor Program | $350 | Research payment | Cash or cash equivalent | A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for N | 2024 | |
| 2024-07-25 | Edwards Lifesciences Corporation | $305 | Long term medical supply or device loan | In-kind items and services | Hemosphere Foresight Module Device, Hemodynamic Monitoring | 2024 | |
| 2024-07-17 | VERTEX PHARMACEUTICALS INCORPORATED | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-07-09 | Mirati Therapeutics, Inc. | $5,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-06-30 | Medtronic, Inc. | $5,251 | Research payment | In-kind items and services | CIP336 Fiasp | 2024 | |
| 2024-05-03 | Siemens Medical Solutions USA, Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-05-03 | National Marrow Donor Program | $350 | Research payment | Cash or cash equivalent | A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for N | 2024 | |
| 2024-04-26 | National Marrow Donor Program | $1,685 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-04-24 | Takeda Pharmaceuticals U.S.A., Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2024 | ||
| 2024-04-18 | MED-EL Corporation | $1,200 | Grant | Cash or cash equivalent | Mi1250 SYNCHRONY 2 FLEXsoft Device, Cochlear Implant | 2024 | |
| 2024-03-25 | Takeda Pharmaceuticals U.S.A., Inc. | $10,000 | Grant | Cash or cash equivalent | 2024 | ||
| 2024-03-17 | Insulet Corporation | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Omnipod Device, Insulin Pump | 2024 | |
| 2024-03-13 | OrthoPediatrics Corp. | $27,486 | Grant (4 payments) | Cash or cash equivalent | 2024 | ||
| 2024-03-13 | OrthoPediatrics Corp. | $14,550 | Grant (4 payments) | Cash or cash equivalent | 2024 | ||
| 2024-03-01 | AstraZeneca Pharmaceuticals LP | $25 | Charitable Contribution | Cash or cash equivalent | 2024 | ||
| 2024-01-26 | National Marrow Donor Program | $2,325 | Research payment | Cash or cash equivalent | A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for N | 2024 | |
| 2024-01-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | $1,061 | Research payment | Cash or cash equivalent | PRADAXA Drug, CARDIOVASCULAR | US observational study of DE oral pellets in patients <12 y | 2024 |
| 2024-01-15 | Novartis Pharmaceuticals Corporation | $3,275 | Research payment | Cash or cash equivalent | KYMRIAH Drug, Oncology | A single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic | 2024 |
| 2024-01-12 | National Marrow Donor Program | $2,190 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-01-11 | Sarepta Therapeutics, Inc. | $725 | Research payment | Cash or cash equivalent | SRP-9003-301 | 2024 | |
| 2024-01-11 | Sarepta Therapeutics, Inc. | $540 | Research payment | Cash or cash equivalent | SRP-9003-301 | 2024 | |
| 2024-01-11 | Sarepta Therapeutics, Inc. | $391 | Research payment | Cash or cash equivalent | SRP-9003-301 | 2024 | |
| 2024-01-11 | Sarepta Therapeutics, Inc. | $303 | Research payment | Cash or cash equivalent | SRP-9003-301 | 2024 | |
| 2024-01-11 | Sarepta Therapeutics, Inc. | $38 | Research payment | Cash or cash equivalent | SRP-9003-301 | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In San Diego, CA, county San Diego County, CA, state California; placed by its city name.
| Measure | Place (city or town) San Diego, CA | County San Diego County, CA | State California |
|---|---|---|---|
| Population B01003 | 1,389,526 | 3,288,774 | 39,287,377 |
| Population, 2020 census P1 | 1,386,932 | 3,298,634 | 39,538,223 |
| Median age B01002 | 36.2 | 37.3 | 37.9 |
| Under 18 B01001 | 18.4% | 20.9% | 22.0% |
| 65 and over B01001 | 14.6% | 15.4% | 15.7% |
| Households B11001 | 530,412 | 1,171,278 | 13,548,091 |
| Foreign born B05002 | 25.1% | 22.8% | 27.0% |
| Median household income B19013 | $108,077 | $106,268 | $99,122 |
| Median family income B19113 | $128,006 | $122,377 | $113,346 |
| Per capita income B19301 | $57,083 | $51,976 | $49,513 |
| Poverty rate B17001 | 11.0% | 10.3% | 12.0% |
| Unemployment rate B23025 | 6.0% | 6.1% | 6.6% |
| Civilian labor force B23025 | 755,893 | 1,689,384 | 20,068,466 |
| Mean commute (minutes) B08013 | 23.5 | 25.5 | 28.7 |
| Bachelor's degree or higher B15003 | 51.0% | 43.2% | 37.1% |
| Housing units B25001 | 568,668 | 1,250,641 | 14,644,735 |
| Owner-occupied B25003 | 47.3% | 54.6% | 55.9% |
| Renters B25003 | 52.7% | 45.4% | 44.1% |
| Median home value B25077 | $906,700 | $854,700 | $734,700 |
| Median gross rent B25064 | $2,313 | $2,246 | $2,036 |
| White, not Hispanic B03002 | 40.9% | 42.4% | 33.8% |
| Black B03002 | 5.3% | 4.4% | 5.2% |
| Hispanic or Latino B03002 | 29.8% | 34.6% | 40.2% |
| Asian B03002 | 17.3% | 12.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in San Diego, CA.
Comments